BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP, Trochu JN, Butler J. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017;3:17058. [PMID: 28836616 DOI: 10.1038/nrdp.2017.58] [Cited by in Crossref: 72] [Cited by in F6Publishing: 82] [Article Influence: 14.4] [Reference Citation Analysis]
Number Citing Articles
1 Huerta-Delgado AS, Roffe-Vazquez DN, Luna-Ceron E, Gonzalez-Gil AM, Casillas-Fikentscher A, Villarreal-Calderon JR, Enriquez C, de la Peña-Almaguer E, Castillo EC, Silva-Platas C, Garcia-Rivas G, Elizondo-Montemayor L. Association of irisin levels with cardiac magnetic resonance, inflammatory, and biochemical parameters in patients with chronic heart failure versus controls. Magn Reson Imaging 2022:S0730-725X(22)00117-5. [PMID: 35842196 DOI: 10.1016/j.mri.2022.07.006] [Reference Citation Analysis]
2 Huang L, Liang L, Tian P, Zhao L, Chen Y, Huang Y, Zhou Q, Zhai M, Zhang Y, Ambrosio G, Zhang J. D-dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes. ESC Heart Fail 2022. [PMID: 35747927 DOI: 10.1002/ehf2.14049] [Reference Citation Analysis]
3 Okhovatian S, Mohammadi MH, Rafatian N, Radisic M. Engineering Models of the Heart Left Ventricle. ACS Biomater Sci Eng 2022;8:2144-60. [PMID: 35523206 DOI: 10.1021/acsbiomaterials.1c00636] [Reference Citation Analysis]
4 Silva Andrade NS, Almeida L, Noronha I, Lima JM, Eriko Tenório de França E, Pedrosa R, Siqueira F, Onofre T. Analysis of respiratory muscle strength and its relationship with functional capacity between different field tests in patients with heart failure. Physiother Theory Pract 2022;:1-11. [PMID: 35619283 DOI: 10.1080/09593985.2022.2077270] [Reference Citation Analysis]
5 Vergaro G, Gentile F, Aimo A, Januzzi JL Jr, Richards AM, Lam CSP, de Boer RA, Meems LMG, Latini R, Staszewsky L, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD, Ling LH, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Troughton R, Doughty RN, Devlin G, Lund M, Giannoni A, Passino C, Emdin M. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure. ESC Heart Fail 2022. [PMID: 35510529 DOI: 10.1002/ehf2.13883] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shoaei Matin S, Shidfar F, Naderi N, Amin A, Hosseini-baharanchi FS, Dehnad A. The Effect of Synbiotic Consumption on Serum NTproBNP, hsCRP and Blood Pressure in Patients With Chronic Heart Failure: A Randomized, Triple-Blind, Controlled Trial. Front Nutr 2022;8:822498. [DOI: 10.3389/fnut.2021.822498] [Reference Citation Analysis]
7 Chausiaux OE, Keyser M, Williams GP, Nieznański M, Downer PJ, Garnett RE, Berry R, Husheer SLG. Heart failure decompensation alerts in a patient's home using an automated, AI-driven, point-of-care device. BMJ Case Rep 2022;15:e248682. [PMID: 35414581 DOI: 10.1136/bcr-2021-248682] [Reference Citation Analysis]
8 Shanks J, Abukar Y, Lever NA, Pachen M, LeGrice IJ, Crossman DJ, Nogaret A, Paton JFR, Ramchandra R. Reverse re-modelling chronic heart failure by reinstating heart rate variability. Basic Res Cardiol 2022;117:4. [PMID: 35103864 DOI: 10.1007/s00395-022-00911-0] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bachtiger P, Petri CF, Scott FE, Ri Park S, Kelshiker MA, Sahemey HK, Dumea B, Alquero R, Padam PS, Hatrick IR, Ali A, Ribeiro M, Cheung W, Bual N, Rana B, Shun-shin M, Kramer DB, Fragoyannis A, Keene D, Plymen CM, Peters NS. Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study. The Lancet Digital Health 2022;4:e117-25. [DOI: 10.1016/s2589-7500(21)00256-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Han Y, Huang L, Zhong G, Chang X, Zhu Q, Xu M, Mingtai C, Men L, Wang L. Evaluation of the safety and efficacy of Zhenwu decoction as adjuvant therapy for the treatment of heart failure with reduced ejection fraction: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28672. [PMID: 35089212 DOI: 10.1097/MD.0000000000028672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Drapkina OM, Shepel RN, Dzhioeva ON. Natriuretic peptides: new challenges — new solutions. Cardiovasc Ther Prev 2021;20:3102. [DOI: 10.15829/1728-8800-2021-3102] [Reference Citation Analysis]
12 He H, Baka T, Balschi J, Motani AS, Nguyen KK, Liu Q, Slater R, Rock B, Wang C, Hale C, Karamanlidis G, Hartman JJ, Malik FI, Reagan JD, Luptak I. A Novel Small Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics. Circ Heart Fail 2021. [PMID: 34743528 DOI: 10.1161/CIRCHEARTFAILURE.121.009195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Raj P, Thandapilly SJ, Wigle J, Zieroth S, Netticadan T. A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure. Molecules 2021;26:6600. [PMID: 34771008 DOI: 10.3390/molecules26216600] [Reference Citation Analysis]
14 Li C, Zhao M, Xiao L, Wei H, Wen Z, Hu D, Yu B, Sun Y, Gao J, Shen X, Zhang Q, Cao H, Huang J, Huang W, Li K, Huang M, Ni L, Yu T, Ji L, Xu Y, Liu G, Konerman MC, Zheng L, Wen Wang D. Prognostic Value of Elevated Levels of Plasma N-Acetylneuraminic Acid in Patients With Heart Failure. Circ Heart Fail 2021;14:e008459. [PMID: 34711067 DOI: 10.1161/CIRCHEARTFAILURE.121.008459] [Reference Citation Analysis]
15 Tourki B, Halade GV. Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity. Front Cardiovasc Med 2021;8:695952. [PMID: 34409075 DOI: 10.3389/fcvm.2021.695952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Charles E, Dumont BL, Bonneau S, Neagoe PE, Villeneuve L, Räkel A, White M, Sirois MG. Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs). BMC Immunol 2021;22:51. [PMID: 34344299 DOI: 10.1186/s12865-021-00442-8] [Reference Citation Analysis]
17 Martens P, Kooij J, Maessen L, Dauw J, Dupont M, Mullens W. The importance of developing hyperkalaemia in heart failure during long-term follow-up. Acta Cardiol 2021;76:589-97. [PMID: 32264757 DOI: 10.1080/00015385.2020.1748346] [Reference Citation Analysis]
18 Gupta P, Wen H, Di Francesco L, Ayazi F. Detection of pathological mechano-acoustic signatures using precision accelerometer contact microphones in patients with pulmonary disorders. Sci Rep 2021;11:13427. [PMID: 34183695 DOI: 10.1038/s41598-021-92666-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Lahoz R, Proudfoot C, Fonseca AF, Loefroth E, Corda S, Jackson J, Cotton S, Studer R. Caregivers of Patients with Heart Failure: Burden and the Determinants of Health-Related Quality of Life. Patient Prefer Adherence 2021;15:1153-64. [PMID: 34079236 DOI: 10.2147/PPA.S297816] [Reference Citation Analysis]
20 Zhou Q, Li P, Zhao H, Xu X, Li S, Zhao J, Xu D, Zeng Q. Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage? Front Cardiovasc Med 2021;8:678121. [PMID: 34113665 DOI: 10.3389/fcvm.2021.678121] [Reference Citation Analysis]
21 Rossides M, Kullberg S, Grunewald J, Eklund A, Di Giuseppe D, Askling J, Arkema EV. Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden. Heart 2021:heartjnl-2021-319129. [PMID: 34021039 DOI: 10.1136/heartjnl-2021-319129] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Wang Y, Pan W, Bai X, Wang X, Wang Y, Yin Y. microRNA-454-mediated NEDD4-2/TrkA/cAMP axis in heart failure: Mechanisms and cardioprotective implications. J Cell Mol Med 2021;25:5082-98. [PMID: 33949117 DOI: 10.1111/jcmm.16491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med 2021;8:650278. [PMID: 34026868 DOI: 10.3389/fcvm.2021.650278] [Reference Citation Analysis]
24 Wang YY, Gao B, Yang Y, Jia SB, Ma XP, Zhang MH, Wang LJ, Ma AQ, Zhang QN. Histone deacetylase 3 suppresses the expression of SHP-1 via deacetylation of DNMT1 to promote heart failure. Life Sci 2021;:119552. [PMID: 33932446 DOI: 10.1016/j.lfs.2021.119552] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Koren O, Darawsha H, Rozner E, Benhamou D, Turgeman Y. Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up. BMC Cardiovasc Disord 2021;21:199. [PMID: 33882853 DOI: 10.1186/s12872-021-01982-y] [Reference Citation Analysis]
26 Bakogiannis C, Tsarouchas A, Mouselimis D, Lazaridis C, Theofillogianakos EK, Billis A, Tzikas S, Fragakis N, Bamidis PD, Papadopoulos CE, Vassilikos VP. A Patient-Oriented App (ThessHF) to Improve Self-Care Quality in Heart Failure: From Evidence-Based Design to Pilot Study. JMIR Mhealth Uhealth 2021;9:e24271. [PMID: 33847599 DOI: 10.2196/24271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lu Y, Li F, Fan Y, Yang Y, Chen M, Xi J. Effect of SGLT-2 inhibitors on cardiovascular outcomes in heart failure patients: A meta-analysis of randomized controlled trials. Eur J Intern Med 2021;87:20-8. [PMID: 33824055 DOI: 10.1016/j.ejim.2021.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Liu YT, Lai JZ, Zhai FF, Han F, Zhou LX, Ni J, Yao M, Tian Z, Zhu YL, Chen W, Bai H, Wang H, Zhang DD, Cui LY, Jin ZY, Zhu YC, Zhang SY. Right ventricular systolic function is associated with health-related quality of life: a cross-sectional study in community-dwelling populations. Ann Transl Med 2021;9:640. [PMID: 33987338 DOI: 10.21037/atm-20-6845] [Reference Citation Analysis]
29 Zhihao L, Jingyu N, Lan L, Michael S, Rui G, Xiyun B, Xiaozhi L, Guanwei F. SERCA2a: a key protein in the Ca2+ cycle of the heart failure. Heart Fail Rev 2020;25:523-35. [PMID: 31701344 DOI: 10.1007/s10741-019-09873-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
30 Gou D, Zhou J, Song Q, Wang Z, Bai X, Zhang Y, Zuo M, Wang F, Chen A, Yousaf M, Yang Z, Peng H, Li K, Xie W, Tang J, Yao Y, Han M, Ke T, Chen Q, Xu C, Wang Q. Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish. Acta Physiol (Oxf) 2021;231:e13567. [PMID: 33032360 DOI: 10.1111/apha.13567] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
31 Na J, Jin H, Wang X, Huang K, Sun S, Li Q, Zhang W. The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure. Cell Biosci 2021;11:31. [PMID: 33549119 DOI: 10.1186/s13578-020-00523-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Osokina A, Karetnikova V, Polikutina O, Ivanova A, Gruzdeva O, Dyleva Y, Kokov A, Brel N, Pecherina T, Barbarash O. Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction. Aging (Albany NY) 2021;13:194-203. [PMID: 33431713 DOI: 10.18632/aging.202495] [Reference Citation Analysis]
33 Tian Y, Yang J, Lan M, Zou T. Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure. Aging (Albany NY) 2020;12:26221-35. [PMID: 33401250 DOI: 10.18632/aging.202405] [Reference Citation Analysis]
34 Li H, Cui Y, Tian J, Yang H, Zhang Q, Wang K, Han Q, Zhang Y. A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction. Open Med (Wars) 2020;15:644-53. [PMID: 33336021 DOI: 10.1515/med-2020-0209] [Reference Citation Analysis]
35 Klapper-Goldstein H, Verma A, Elyagon S, Gillis R, Murninkas M, Pittala S, Paul A, Shoshan-Barmatz V, Etzion Y. VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism. Sci Rep 2020;10:22101. [PMID: 33328613 DOI: 10.1038/s41598-020-79056-w] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
36 Kanki M, Young MJ. Corticosteroids and circadian rhythms in the cardiovascular system. Curr Opin Pharmacol 2021;57:21-7. [PMID: 33207294 DOI: 10.1016/j.coph.2020.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Redwine LS, Wilson K, Pung MA, Chinh K, Rutledge T, Mills PJ, Smith B. A Randomized Study Examining the Effects of Mild-to-Moderate Group Exercises on Cardiovascular, Physical, and Psychological Well-being in Patients With Heart Failure. J Cardiopulm Rehabil Prev 2019;39:403-8. [PMID: 31397771 DOI: 10.1097/HCR.0000000000000430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
38 Sharma K, Mok Y, Kwak L, Agarwal SK, Chang PP, Deswal A, Shah AM, Kitzman DW, Wruck LM, Loehr LR, Heiss G, Coresh J, Rosamond WD, Solomon SD, Matsushita K, Russell SD. Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study. J Am Heart Assoc 2020;9:e014669. [PMID: 32924735 DOI: 10.1161/JAHA.119.014669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Rolski F, Błyszczuk P. Complexity of TNF-α Signaling in Heart Disease. J Clin Med 2020;9:E3267. [PMID: 33053859 DOI: 10.3390/jcm9103267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
40 von Haehling S, Hasenfuß G. [Cardio-oncology: At the crossroads between two fields]. Internist (Berl) 2020;61:1111-3. [PMID: 33025121 DOI: 10.1007/s00108-020-00888-9] [Reference Citation Analysis]
41 Melnikov S, Abuhazira M, Golobov D, Yaari V, Jaarsma T, Ben Gal T. Factors associated with body image among patients with an implanted left ventricular assist device. Heart Lung 2020;49:803-7. [PMID: 33010518 DOI: 10.1016/j.hrtlng.2020.08.022] [Reference Citation Analysis]
42 Borovac JA, D'Amario D, Bozic J, Glavas D. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol 2020; 12(8): 373-408 [PMID: 32879702 DOI: 10.4330/wjc.v12.i8.373] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
43 Migliavaca CB, Stein C, Colpani V, Eibel B, Bgeginski R, Simões MV, Rohde LE, Falavigna M. High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis. Open Heart 2020;7:e001228. [PMID: 32820054 DOI: 10.1136/openhrt-2019-001228] [Reference Citation Analysis]
44 Ding J, Liu S, Qian W, Wang J, Chu C, Wang J, Li K, Yu Y, Xu G, Mao Z, Xiao P, Yu Y, Chen F. Swietenine extracted from Swietenia relieves myocardial hypertrophy induced by isoprenaline in mice. Environ Toxicol 2020;35:1343-51. [PMID: 32686902 DOI: 10.1002/tox.22999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sadeghi M, Khosrawi S, Heshmat-Ghahdarijani K, Gheisari Y, Roohafza H, Mansoorian M, Hoseini SG. Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial. ESC Heart Fail 2020;7:3142-50. [PMID: 32618134 DOI: 10.1002/ehf2.12829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Jones TW, Smith SE, Van Tuyl JS, Newsome AS. Sepsis With Preexisting Heart Failure: Management of Confounding Clinical Features. J Intensive Care Med 2021;36:989-1012. [PMID: 32495686 DOI: 10.1177/0885066620928299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Nayak A, Liu C, Mehta A, Ko YA, Tahhan AS, Dhindsa DS, Uppal K, Jones DP, Butler J, Morris AA, Quyyumi AA. N8-Acetylspermidine: A Polyamine Biomarker in Ischemic Cardiomyopathy With Reduced Ejection Fraction. J Am Heart Assoc 2020;9:e016055. [PMID: 32458724 DOI: 10.1161/JAHA.120.016055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Pinar AA, Scott TE, Huuskes BM, Tapia Cáceres FE, Kemp-harper BK, Samuel CS. Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis. Pharmacology & Therapeutics 2020;209:107511. [DOI: 10.1016/j.pharmthera.2020.107511] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
49 Bytyçi I, Dini FL, Bajraktari A, Pugliese NR, D'Agostino A, Bajraktari G, Lindqvist P, Henein MY. Speckle Tracking-Derived Left Atrial Stiffness Predicts Clinical Outcome in Heart Failure Patients with Reduced to Mid-Range Ejection Fraction. J Clin Med 2020;9:E1244. [PMID: 32344825 DOI: 10.3390/jcm9051244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
50 Toribio M, Neilan TG, Zanni MV. Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations. Curr HIV/AIDS Rep 2019;16:371-80. [PMID: 31482297 DOI: 10.1007/s11904-019-00458-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
51 Marengoni A, Zucchelli A, Vetrano DL, Aloisi G, Brandi V, Ciutan M, Panait CL, Bernabei R, Onder G, Palmer K. Heart failure, frailty, and pre-frailty: A systematic review and meta-analysis of observational studies. Int J Cardiol 2020;316:161-71. [PMID: 32320778 DOI: 10.1016/j.ijcard.2020.04.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
52 Shah D, Lu X, Paly VF, Tsintzos SI, May DM. Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data. J Med Econ 2020;23:690-7. [PMID: 32207659 DOI: 10.1080/13696998.2020.1746316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Patel N, Chakraborty S, Bandyopadhyay D, Amgai B, Hajra A, Atti V, Das A, Ghosh RK, Deedwania PC, Aronow WS, Lavie CJ, Di Tullio MR, Vaduganathan M, Fonarow GC. Association between depression and readmission of heart failure: A national representative database study. Prog Cardiovasc Dis 2020;63:585-90. [PMID: 32224112 DOI: 10.1016/j.pcad.2020.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
54 Malangu B, Lanier GM, Frishman WH. Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic Option. Cardiol Rev 2021;29:48-53. [PMID: 32282391 DOI: 10.1097/CRD.0000000000000307] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Gupta P, Moghimi MJ, Jeong Y, Gupta D, Inan OT, Ayazi F. Precision wearable accelerometer contact microphones for longitudinal monitoring of mechano-acoustic cardiopulmonary signals. NPJ Digit Med 2020;3:19. [PMID: 32128449 DOI: 10.1038/s41746-020-0225-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
56 Liu J, Ai Y, Niu X, Shang F, Li Z, Liu H, Li W, Ma W, Chen R, Wei T, Li X, Li X. Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation. Chem Biol Interact 2020;317:108972. [PMID: 32017914 DOI: 10.1016/j.cbi.2020.108972] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
57 Cai G, Liang S, Li C, Meng X, Yu J. Left Ventricular Systolic Dysfunction Is a Possible Independent Risk Factor of Radiation Pneumonitis in Locally Advanced Lung Cancer Patients. Front Oncol 2019;9:1511. [PMID: 32039006 DOI: 10.3389/fonc.2019.01511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Mancini A, Fuvuzzi AMR, Bruno C, Nicolazzi MA, Vergani E, Ciferri N, Silvestrini A, Meucci E, Nicolotti N, D'Assante R, Cittadini A. Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity. Int J Endocrinol 2020;2020:5798146. [PMID: 32411227 DOI: 10.1155/2020/5798146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
59 Mastikhina O, Moon BU, Williams K, Hatkar R, Gustafson D, Mourad O, Sun X, Koo M, Lam AYL, Sun Y, Fish JE, Young EWK, Nunes SS. Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing. Biomaterials 2020;233:119741. [PMID: 31927251 DOI: 10.1016/j.biomaterials.2019.119741] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
60 Xu J, Li X, Zhang F, Tang L, Wei J, Lei X, Wang H, Zhang Y, Li D, Tang X, Li G, Tang S, Wu H, Yang H. Integrated UPLC-Q/TOF-MS Technique and MALDI-MS to Study of the Efficacy of YiXinshu Capsules Against Heart Failure in a Rat Model. Front Pharmacol 2019;10:1474. [PMID: 31866870 DOI: 10.3389/fphar.2019.01474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
61 Amgalan D, Kitsis RN. A mouse model for the most common form of heart failure. Nature 2019;568:324-5. [PMID: 30980035 DOI: 10.1038/d41586-019-00983-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
62 Barton M, Yanagisawa M. Endothelin: 30 Years From Discovery to Therapy. Hypertension 2019;74:1232-65. [PMID: 31679425 DOI: 10.1161/HYPERTENSIONAHA.119.12105] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 12.7] [Reference Citation Analysis]
63 Quiroga B, de Santos A, Sapiencia D, Saharaui Y, Álvarez-chiva V. Experiencia clínica con sacubitrilo/valsartán en pacientes con insuficiencia renal: la visión del nefrólogo. Nefrología 2019;39:646-52. [DOI: 10.1016/j.nefro.2019.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
64 Quiroga B, de Santos A, Sapiencia D, Saharaui Y, Álvarez-chiva V. Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view. Nefrología (English Edition) 2019;39:646-52. [DOI: 10.1016/j.nefroe.2019.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
65 Prasada S, Shah SJ, Michos ED, Polak JF, Greenland P. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis. Vasc Med 2019;24:501-10. [PMID: 31480898 DOI: 10.1177/1358863X19870602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Ferrari F, Menegazzo WR. Global Longitudinal Strain or Measurement of Ejection Fraction: Which Method is Better in Stratifying Patients with Heart Failure? Arq Bras Cardiol 2019;113:195-6. [PMID: 31483015 DOI: 10.5935/abc.20190151] [Reference Citation Analysis]
67 Kalogeropoulos AP, Kim S, Rawal S, Jadonath A, Tangutoori R, Georgiopoulou V. Serial Changes in Left Ventricular Ejection Fraction and Outcomes in Outpatients With Heart Failure and Preserved Ejection Fraction. Am J Cardiol 2019;124:729-35. [PMID: 31272702 DOI: 10.1016/j.amjcard.2019.05.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
68 Gulea C, Zakeri R, Quint JK. Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study. International Journal of Cardiology 2019;290:113-8. [DOI: 10.1016/j.ijcard.2019.04.087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
69 Lakhani I, Leung KSK, Tse G, Lee APW. Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Front Physiol 2019;10:874. [PMID: 31333505 DOI: 10.3389/fphys.2019.00874] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
70 Sickinghe AA, Korporaal SJA, den Ruijter HM, Kessler EL. Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction. Front Endocrinol (Lausanne) 2019;10:442. [PMID: 31333587 DOI: 10.3389/fendo.2019.00442] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
71 Park J, Lee J, Kwon A, Choi HJ, Chung HS, Hong SH, Park CS, Choi JH, Chae MS. The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation. PLoS One 2019;14:e0215603. [PMID: 31013321 DOI: 10.1371/journal.pone.0215603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
72 Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci 2019;20:E1820. [PMID: 31013779 DOI: 10.3390/ijms20081820] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 13.7] [Reference Citation Analysis]
73 Doshi R, Patel K, Decter D, Gupta R, Meraj P. Trends in the Utilisation and In-Hospital Mortality Associated With Short-Term Mechanical Circulatory Support for Heart Failure With Reduced Ejection Fraction. Heart, Lung and Circulation 2019;28:e47-50. [DOI: 10.1016/j.hlc.2018.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
74 Assaad M, Sarsam S, Naqvi A, Zughaib M. CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience. JRSM Cardiovasc Dis 2019;8:2048004019833290. [PMID: 30828447 DOI: 10.1177/2048004019833290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
75 Engineer A, Albers SS, Kucey AS. The role of submaximal exercise-induced skeletal muscle remodelling in heart failure with reduced ejection fraction patients. J Physiol 2019;597:669-71. [PMID: 30488441 DOI: 10.1113/JP277307] [Reference Citation Analysis]
76 Vargas-Ramirez L, Gonzalez-Garcia M, Franco-Reyes C, Bazurto-Zapata MA. Severe sleep apnea, Cheyne-Stokes respiration and desaturation in patients with decompensated heart failure at high altitude. Sleep Sci 2018;11:146-51. [PMID: 30455846 DOI: 10.5935/1984-0063.20180028] [Reference Citation Analysis]
77 Qian W, Yu D, Zhang J, Hu Q, Tang C, Liu P, Ye P, Wang X, Lv Q, Chen M, Sheng L. Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway. Front Pharmacol 2018;9:896. [PMID: 30150938 DOI: 10.3389/fphar.2018.00896] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
78 Miller LW. Cardiac Ejection Fraction: New Insights About its Dynamic Nature. J Am Coll Cardiol 2018;72:602-4. [PMID: 30071988 DOI: 10.1016/j.jacc.2018.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Chen G, Bracamonte-Baran W, Diny NL, Hou X, Talor MV, Fu K, Liu Y, Davogustto G, Vasquez H, Taegtmeyer H, Frazier OH, Waisman A, Conway SJ, Wan F, Čiháková D. Sca-1+ cardiac fibroblasts promote development of heart failure. Eur J Immunol 2018;48:1522-38. [PMID: 29953616 DOI: 10.1002/eji.201847583] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
80 Polina ER, Araújo RRCV, Sbruzzi RC, Biolo A, Rohde LE, Clausell N, Dos Santos KG. Relationship of polymorphisms in the tissue inhibitor of metalloproteinase (TIMP)-1 and -2 genes with chronic heart failure. Sci Rep 2018;8:9446. [PMID: 29930267 DOI: 10.1038/s41598-018-27857-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hlavatá K, Hošková L, Franeková J, Jabor A, Kautzner J, Melenovský V, Beneš J. Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice. Cor Vasa 2018;60:e209-14. [DOI: 10.1016/j.crvasa.2017.10.009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Shen D, Shen M, Liang H, Tang J, Wang B, Liu C, Wang P, Dong J, Li L, Zhang J, Caranasos TG. Therapeutic benefits of CD90-negative cardiac stromal cells in rats with a 30-day chronic infarct. J Cell Mol Med 2018;22:1984-91. [PMID: 29341439 DOI: 10.1111/jcmm.13517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]